KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nova (NVMI) Intangibles (2016 - 2025)

Nova filings provide 11 years of Intangibles readings, the most recent being $45.8 million for Q4 2025.

  • On a quarterly basis, Intangibles rose 45.65% to $45.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $45.8 million, a 45.65% increase, with the full-year FY2025 number at $45.8 million, up 45.65% from a year prior.
  • Intangibles hit $45.8 million in Q4 2025 for Nova, down from $48.1 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $50.4 million in Q2 2025 to a low of $2.6 million in Q4 2021.
  • Median Intangibles over the past 5 years was $40.3 million (2023), compared with a mean of $34.4 million.
  • Biggest five-year swings in Intangibles: crashed 48.59% in 2021 and later skyrocketed 1575.74% in 2022.
  • Nova's Intangibles stood at $2.6 million in 2021, then surged by 1575.74% to $43.6 million in 2022, then dropped by 10.1% to $39.2 million in 2023, then dropped by 19.72% to $31.5 million in 2024, then soared by 45.65% to $45.8 million in 2025.
  • The last three reported values for Intangibles were $45.8 million (Q4 2025), $48.1 million (Q3 2025), and $50.4 million (Q2 2025) per Business Quant data.